Gabapentin Market Report and Forecast 2025-2034

The global gabapentin market size was valued at USD 2.10 Billion in 2024, driven by the increasing use of gabapentin as a pain reliever drug across the globe. The market is anticipated to grow at a CAGR of 5.00% during the forecast period of 2025-2034 to achieve a value of USD 3.42 Billion by 2034.

Gabapentin: Introduction

Gabapentin tablets, capsules, and oral solutions are used to control seizures of certain type by combining them with other medications. They are also used as a pain reliever for postherpetic neuralgia that are basically the sensations or body aches occurring after person has had a shingle attack. It is also used to endure the pain of diabetic neuropathies and hot flashes in women who are undergoing treatment for breast cancer or the ones that have had their menopause.

Global Gabapentin Market Analysis

The major factors aiding the market growth are the undergoing development of new formulation for gabapentin in order to enhance efficacy and adherence of patient in the gabapentin market. The growing evidence of research towards the use of gabapentin to reduce alcohol dependence could possibly contribute to the expansion of the market. The escalating adoption of telemedicine, exploration of combination therapies is among some other key trends propelling the global gabapentin market expansion.

Additionally, the increased off-label prescription of gabapentin for conditions such as anxiety disorders, insomnia, and fibromyalgia, among others is also driving the demand for gabapentin. Due to the increasing geriatric population and lifestyle changes, the prevalence of chronic pain conditions such as neuropathic pain, postherpetic neuralgia, and diabetic neuropathy has also increased, owing to the market growth as gabapentin is the main prescribed drug for the treatment of such conditions. Because of its well-known opioid-sparing properties, gabapentin can be used to treat pain along with less potent opioids.

Gabapentin can potentially treat several anxiety disorders such as bipolar disorder, and other mental health conditions, which is why it has gained attention in the market. The growing emphasis on mental health and the need for effective pharmacological interventions are directly contributing to the global gabapentin market development.

Global Gabapentin Market Segmentations

The EMR’s report titled “Gabapentin Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• Capsule
• Tablet

Market Breakup by Application

• Epilepsy
• Neuropathic Pain
• Restless Legs Syndrome

Market Breakup by Route of Administration

• Oral
• Parenteral
• Intravenous

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Gabapentin Market Overview

There are several major factors that are driving the market growth such as the increasing use of gabapentin as a pain reliever drug in the market. The rising incidence of chronic pains as shingles, diabetic neuropathy, and other pains that are hard to cure with the use of basic medicines are also contributing to the market growth.

Additionally, escalating demand for generic drug development which is comparatively less expensive than the drugs that are undersigned with name of big brands is propelling the growth of the market. Some other factors driving the market growth include the affordability and availability of Gabapentin in countries that are still developing with reasonable healthcare budgets. Gabapentin is available in different form as topical gels, oral solutions, capsules, tablets, and creams, and this factor is also a major driver for the gabapentin market growth. The increase in research and development to find new applications of gabapentin and develop new formulations to enhance the efficacy is a driver owing to the market growth.

Gabapentin has also been available in generic forms, which in turn is increasing competition among generic manufacturers. This competition would probably lead to lower prices and increased availability of gabapentin, driving market growth.

Gabapentin Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Zydus Pharmaceuticals, Inc.
• Glenmark Pharmaceuticals Limited
• Sun Pharmaceutical Industries Ltd.
• Ascend Laboratories, LLC
• Apotex Inc.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma.
• Amneal Pharmaceuticals LLC.
• Cipla
• Pfizer Inc.

*Please Note:* The report will take 5 business days to complete, after order confirmation. Show more